NAKA
Price:
$4.32
Market Cap:
$228.87B
Specializing in the development and financial backing of a global array of Bitcoin-centric businesses, Nakamoto Inc. also provides crucial commercial and financial infrastructure for capital markets. The company, founded in 2019, was originally known as Kindly MD, Inc. but rebranded as Nakamoto Inc. in January 2026. It is headquartered in Nashville, Tennessee.
Industry
Financial - Capital Markets
IPO Date
2024-05-31
Stock Exchange
NASDAQ
Ticker
NAKA
According to Nakamoto Inc.’s latest financial reports and current stock price. The company's current ROE is -84.79%. This represents a change of 230.14% compared to the average of -25.68% of the last 4 quarters.
The mean historical ROE of Nakamoto Inc. over the last ten years is 145.77%. The current -84.79% ROE has changed -158.17% with respect to the historical average. Over the past ten years (40 quarters), NAKA's ROE was at its highest in in the June 2023 quarter at 1.02%. The ROE was at its lowest in in the December 2022 quarter at -117.07%.
Average
145.77%
Median
-10.16%
Minimum
-666.80%
Maximum
1.49%
Discovering the peaks and valleys of Nakamoto Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 1.49%
Minimum Annual Increase = -1319.35%
Minimum Annual ROE = -666.80%
| Year | ROE | Change |
|---|---|---|
| 2025 | -10.16% | -92.79% |
| 2024 | -140.86% | -109.44% |
| 2023 | 1.49% | -323.75% |
| 2022 | -666.80% | -1319.35% |
The current ROE of Nakamoto Inc. (NAKA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
446.98%
5-year avg
145.77%
10-year avg
145.77%
Nakamoto Inc.’s ROE is greater than Agilon Health, Inc. (-146.01%), greater than Definitive Healthcare Corp. (-67.07%), greater than SOPHiA GENETICS S.A. (-140.63%), greater than Lyell Immunopharma, Inc. (-85.71%), greater than Larimar Therapeutics, Inc. (-134.14%), greater than Simulations Plus, Inc. (-49.30%), greater than Cellectis S.A. (-80.61%), greater than Amarin Corporation plc (-7.34%), greater than DBV Technologies S.A. (-130.06%), less than Delcath Systems, Inc. (0.51%),
| Company | ROE | Market cap |
|---|---|---|
| -146.01% | $1.88B | |
| -67.07% | $88.59M | |
| -140.63% | $349.74M | |
| -85.71% | $315.01M | |
| -134.14% | $296.96M | |
| -49.30% | $329.75M | |
| -80.61% | $310.29M | |
| -7.34% | $315.21M | |
| -130.06% | $416.60M | |
| 0.51% | $404.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nakamoto Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nakamoto Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nakamoto Inc.'s ROE?
How is the ROE calculated for Nakamoto Inc. (NAKA)?
What is the highest ROE for Nakamoto Inc. (NAKA)?
What is the 3-year average ROE for Nakamoto Inc. (NAKA)?
What is the 5-year average ROE for Nakamoto Inc. (NAKA)?
How does the current ROE for Nakamoto Inc. (NAKA) compare to its historical average?